Skip to main content
SpringerLink
Log in

The tear cytokine profile in patients with active Graves’ orbitopathy

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

The primary aim of this study is to isolate cytokines specific for active Graves’ orbitopathy (GO) in the tears of affected patients. The secondary aim is to identify other cytokines of interest and to look at the profile of their levels over time.

Methods

This is a prospective pilot study conducted at the Singapore National Eye Centre. A total of 10 patients with active GO and 10 patients from each of 3 control groups were recruited. The 3 control groups were the following: age-matched normal female patients, patients with GO who were clinically inactive and patients with bilateral viral conjunctivitis. Tears from patients from the control groups were collected on a single visit. For patients with active GO, tears were collected on presentation, at 6 months, 12 months and 18 months.

Results

Of all the cytokines examined, only IL-7 yielded a difference when the concentration in patients with active GO was compared with concentrations in all the control groups. This difference was most significant at the 18-month follow-up visit.

Conclusions

Low concentrations of IL-7 in tears exhibit specificity for active GO in patients nearly 2 years from the clinical onset of activity. Although using IL-7 in tears as a biomarker for disease activity may be limited due to its late manifestation, targeting immune restitution using IL-7 may have disease modifying effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. R.S. Bahn, Graves’ ophthalmolopathy. N. Engl. J. Med. 362, 726–738 (2010)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. S.M. McLachlan, M.F. Prummel, B. Rapoport, Cell-mediated or humoral immunity in Graves’ ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J. Clin. Endocrinol. Metab. 78, 1070–1074 (1994)

    CAS  PubMed  Google Scholar 

  3. R.H. Chen, W.C. Chen, C.T. Chang et al., Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves’ disease. J. Clin. Lab. Anal. 19, 133–138 (2005)

    Article  CAS  PubMed  Google Scholar 

  4. M. Salvi, M. Pedrazzoni, G. Girasole, N. Giuliani, R. Minelli, J.R. Wall, E. Roti, Serum concentrations of proinflammatory cytokines in Graves’ disease, Effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur. J. Endocrinol. 143, 197–202 (2000)

    Article  CAS  PubMed  Google Scholar 

  5. M.A. Harris, T. Realini, J.P. Hogg, J.A. Sivak-Callcott, CT dimensions of the lacrimal gland in Graves’ orbitopathy. Ophthal. Plast. Reconstr. Surg. 28, 69–72 (2012)

    Article  PubMed  Google Scholar 

  6. A.K. Eckstein, A. Finkenrath, A. Heiligenhaus et al., Dry eye syndrome in thyroid = associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol. 82, 291–297 (2004)

    Article  CAS  Google Scholar 

  7. D.H. Jacobson, C.A. Gorman, Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment. Endocr. Rev. 5, 200–220 (1984)

    Article  CAS  PubMed  Google Scholar 

  8. D. Huang, N. Xu, Y. Song et al., Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy. Graefes. Arch. Clin. Exp. Ophthalmol. 250, 619–625 (2012)

    Article  CAS  PubMed  Google Scholar 

  9. B. Ujhelyi, P. Gogolak, A. Erdei et al., Graves’ orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines. Thyroid 22, 407–414 (2012)

    Article  CAS  PubMed  Google Scholar 

  10. N. Boehm, A.I. Riechardt, M. Wiegand, N. Pfeiffer, F.H. Grus, Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest. Ophthalmol. Vis. Sci. 52, 7725–7730 (2011)

    Article  CAS  PubMed  Google Scholar 

  11. S.Y. Lee, S.J. Han, S.M. Nam, S.C. Yoon, J.M. Ahn, T.I. Kim, E.K. Kim, K.Y. Seo, Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients. Am. J. Ophthalmol. 156, 247–253 (2013)

    Article  CAS  PubMed  Google Scholar 

  12. R.S. Chong, Y.Z. Jiang, P.Y. Boey, S.J. Yu, H.M. Htoon, T. Aung, P.T. Khaw, T.T. Wong, Tear cytokine profile in medicated glaucoma patients: effect of monocyte chemoattractant protein 1 on early posttrabeculectomy outcome. Ophthalmology 117, 2353–2358 (2010)

    Article  PubMed  Google Scholar 

  13. Y. Wei, N. Gadaria-Rathod, S. Epstein, P. Asbell, Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures. Invest. Ophthalmol. Vis. Sci. 54, 8327–8336 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. E.B. Cook, Tear cytokines in acute and chronic ocular allergic inflammation. Curr. Opin. Allergy. Clin. Immunol. 4, 441–445 (2004)

    Article  CAS  PubMed  Google Scholar 

  15. R. Kalmann, M.P. Mourits, Late recurrence of unilateral Graves orbitopathy on the contralateral side. Am. J. Ophthalmol. 133, 727–729 (2002)

    Article  PubMed  Google Scholar 

  16. Bartley et al., Diagnostic criteria for Graves’ ophthalmopathy. Am. J. Ophthalmol. 119, 792–795 (1995)

    Article  CAS  PubMed  Google Scholar 

  17. M.P. Mourits, M.F. Prummel, W.M. Wiersinga, L. Koornneef, Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin. Endocrinol. 47, 9–14 (1997)

    Article  CAS  Google Scholar 

  18. L. Bartalena, L. Baldeschi, A.J. Dickinson, A. Eckstein, P. Kendall-Taylor, C. Marcocci, M.P. Mourits, P. Perros, K. Boboridis, A. Boschi, N. Currò, C. Daumerie, G.J. Kahaly, G. Krassas, C.M. Lane, J.H. Lazarus, M. Marinò, M. Nardi, C. Neoh, J. Orgiazzi, S. Pearce, A. Pinchera, S. Pitz, M. Salvi, P. Sivelli, M. Stahl, G. von Arx, W.M. Wiersinga, Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid 18, 333–346 (2008)

    Article  PubMed  Google Scholar 

  19. K.L. Komschlies, K.J. Grzegorzewski, R.H. Wiltrout, Diverse immunological and hematological effects of interleukin-7: implication for clinical application. J. Leukoc. Biol. 58, 623–633 (1995)

    Article  CAS  PubMed  Google Scholar 

  20. A. Ryden, K. Stechova, M. Durilova et al., Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes.Diabetes Metab. Res. Rev. 25, 335–343 (2009)

    CAS  Google Scholar 

  21. S.R. Pickens, N.D. Chamberlain, M.V. Volin et al., Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 63, 2884–2893 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. A. Bikker, C.E. Hack, F.P. Lafeber et al., Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. Curr. Pharm. Des. 18, 2347–2356 (2012)

    Article  CAS  PubMed  Google Scholar 

  23. K. Cai, R. Wei, Interleukin-7 expression in tears and orbital tissues of patients with Graves’ ophthalmopathy. Endocrine 44, 140–144 (2013)

    Article  CAS  PubMed  Google Scholar 

  24. R. Liaria, B. Giacomina, G. Eva et al., IL-7 up-regulates TNF-adependent osteoclastogenesis in patients affected by solid tumor. PLoS ONE 1, 1–9 (2006)

    Article  Google Scholar 

  25. C.A. Dinarello, Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519–550 (2009)

    Article  CAS  PubMed  Google Scholar 

  26. S. Kumar, R.S. Bahn, Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 88, 4246–4250 (2003)

    Article  CAS  PubMed  Google Scholar 

  27. T.J. Cawood, P. Moriarty, C. O’Farrelly, D. O’Shea, The effects of tumour necrosis factor-alpha and interleukin 1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis. Eur. J. Endocrinol. 155, 395–403 (2006)

    Article  CAS  PubMed  Google Scholar 

  28. R.A. Metcalfe, A.P. Weetman, Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid associated ophthalmopathy. Clin. Endocrinol. 40, 67–72 (1994)

    Article  CAS  Google Scholar 

  29. W.G. Kuschner, A. D’Alessandro, H. Wong, P.D. Blanc, Dose dependent cigarette smoking-related inflammatory responses in healthy adults. Eur. Respir. J. 9, 1989–1994 (1996)

    Article  CAS  PubMed  Google Scholar 

  30. L. Bartalena, L. Manetti, M.L. Tanda, E. Dell’Unto, B. Mazzi, R. Rocchi, G. Barbesino, A. Pinchera, C. Marcocci, Soluble interleukin-1 receptor antagonist concentration in patients with Graves’ ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids. Clin. Endocrinol. 52, 647–651 (2000)

    Article  CAS  Google Scholar 

  31. R.J. Simpson, Interleukin-6: structure-function relationships. Protein Sci. 6, 929–955 (1997)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. P. Dolman, 15th International Thyroid Congress, 85th Annual Meeting of the American Thyroid Association, Graves’ Orbitopathy and Surgical Decompression. (2015)

Download references

Acknowledgements

Dr Marcus Lim (in memoriam), a colleague much missed who gave us the original inspiration.

Author information

Authors and Affiliations

  1. Singapore National Eye Centre, Singapore, Singapore

    Morgan Yang, Yvonne Chung, Stephanie Lang, Lay Leng Seah & Audrey Looi

  2. Singapore Eye Research Institute, Singapore, Singapore

    Morgan Yang, Yvonne Chung, Nobuyo Yawata, Lay Leng Seah & Audrey Looi

  3. Department of Medicine, Ophthalmology, Fukuoka Dental College, Fukuoka, Japan

    Nobuyo Yawata

Authors
  1. Morgan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yvonne Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephanie Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nobuyo Yawata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lay Leng Seah
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Audrey Looi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Morgan Yang.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, M., Chung, Y., Lang, S. et al. The tear cytokine profile in patients with active Graves’ orbitopathy. Endocrine 59, 402–409 (2018). https://doi.org/10.1007/s12020-017-1467-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-017-1467-2

Keywords

Search

Navigation